Chargement en cours...
Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment
Anti-angiogenic and vascular disrupting therapies rely on the dependence of tumors on new blood vessels to sustain tumor growth. We previously reported a potent vascular disrupting agent, a theranostic nanosystem consisting of a tumor vasculature-homing peptide (CGKRK) fused to a pro-apoptotic pepti...
Enregistré dans:
| Publié dans: | J Control Release |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819600/ https://ncbi.nlm.nih.gov/pubmed/29030222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.10.006 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|